Divis Laboratories Ltd | DIVI - Operating Profit

Stock Price
6,291.50
Daily Change
0.50 0.01%
Monthly
3.89%
Yearly
10.33%
Q1 Forecast
6,171.47

Divis Laboratories Ltd reported INR7.72B in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Alaunos Therapeutics USD -1.19M 432K Sep/2025
Aurobindo Pharma INR 13.09B 597M Dec/2025
Avita Medical AUD -11.15M 1.19M Jun/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Divis Laboratories Ltd INR 7.72B 30M Dec/2025
Ionis Pharmaceuticals USD -160.18M 300.02M Sep/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Lupin INR 18.97B 757M Dec/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 62M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -21.89M 440K Sep/2025
Tilray USD -20.01M 9.34M Sep/2025
Viatris USD 234.5M 49.1M Sep/2025
Xeris Pharmaceuticals USD 6.73M 2.25M Sep/2025